Table of Contents Author Guidelines Submit a Manuscript
Oxidative Medicine and Cellular Longevity
Volume 2017, Article ID 8192383, 11 pages
https://doi.org/10.1155/2017/8192383
Review Article

Salvianolic Acid Exerts Cardioprotection through Promoting Angiogenesis in Animal Models of Acute Myocardial Infarction: Preclinical Evidence

1Department of Cardiology, The Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University, Wenzhou 32500, China
2Children’s Heart Center, The Second Affiliated Hospital and Yuying Children’s Hospital of Wenzhou Medical University, Institute of Cardiovascular Development and Translational Medicine, Wenzhou Medical University, Wenzhou 325000, China

Correspondence should be addressed to Yan Wang; moc.anis@anihczwyw and Mao-Ping Chu; moc.liamtoh@gnipmhc

Received 27 February 2017; Revised 9 April 2017; Accepted 24 April 2017; Published 21 June 2017

Academic Editor: Pei Luo

Copyright © 2017 Long-jie Yu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. S. Lauer, “Advancing cardiovascular research,” Chest, vol. 141, no. 2, pp. 500–505, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. Organization WH, “World Health Organization report,” May 2014, http://www.who.int/mediacentre/factsheets/fs310/zh/.
  3. K. Q. Luo, H. B. Long, and B. C. Xu, “Reduced apoptosis after acute myocardial infarction by simvastatin,” Cell Biochemistry and Biophysics, vol. 71, no. 2, pp. 735–740, 2015. View at Publisher · View at Google Scholar · View at Scopus
  4. J. Hung, T. H. Teng, J. Finn et al., “Trends from 1996 to 2007 in incidence and mortality outcomes of heart failure after acute myocardial infarction: a population-based study of 20,812 patients with first acute myocardial infarction in Western Australia,” Journal of the American Heart Association, vol. 2, no. 5, article e000172, 2013. View at Publisher · View at Google Scholar
  5. S. Mendis, K. Thygesen, K. Kuulasmaa et al., “World Health Organization definition of myocardial infarction: 2008-09 revision,” International Journal of Epidemiology, vol. 40, no. 1, pp. 139–146, 2011. View at Publisher · View at Google Scholar · View at Scopus
  6. J. E. Dalen, J. S. Alpert, R. J. Goldberg, and R. S. Weinstein, “The epidemic of the 20th century: coronary heart disease,” The American Journal of Medicine, vol. 127, no. 9, pp. 807–812, 2014. View at Publisher · View at Google Scholar · View at Scopus
  7. N. R. Patel, D. V. Patel, P. R. Murumkar, and M. R. Yadav, “Contemporary developments in the discovery of selective factor Xa inhibitors: a review,” European Journal of Medicinal Chemistry, vol. 121, pp. 671–698, 2016. View at Publisher · View at Google Scholar · View at Scopus
  8. Antithrombotic Trialists’ (ATT) Collaboration, C. Baigent, L. Blackwell et al., “Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials,” Lancet, vol. 373, no. 9678, pp. 1849–1860, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. L. R. Jackson, C. Ju, M. Zettler et al., “Outcomes of patients with acute myocardial infarction undergoing percutaneous coronary intervention receiving an oral anticoagulant and dual antiplatelet therapy: a comparison of clopidogrel versus prasugrel from the TRANSLATE-ACS study,” JACC. Cardiovascular Interventions, vol. 8, no. 14, pp. 1880–1889, 2015. View at Publisher · View at Google Scholar · View at Scopus
  10. R. Kones, “Primary prevention of coronary heart disease: integration of new data, evolving views, revised goals, and role of rosuvastatin in management. A comprehensive survey,” Drug Design, Development and Therapy, vol. 5, no. 1, pp. 325–380, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. H. M. Krumholz, S. L. Normand, and Y. Wang, “Trends in hospitalizations and outcomes for acute cardiovascular disease and stroke, 1999-2011,” Circulation, vol. 130, no. 12, pp. 966–975, 2014. View at Publisher · View at Google Scholar · View at Scopus
  12. P. D. Thompson, G. Panza, A. Zaleski, and B. Taylor, “Statin-associated side effects,” Journal of the American College of Cardiology, vol. 67, no. 20, pp. 2395–2410, 2016. View at Publisher · View at Google Scholar · View at Scopus
  13. K. Bledzka, S. S. Smyth, and E. F. Plow, “Integrin alphaIIbbeta3: from discovery to efficacious therapeutic target,” Circulation Research, vol. 112, no. 8, pp. 1189–1200, 2013. View at Publisher · View at Google Scholar · View at Scopus
  14. G. Scharbert, L. Wetzel, W. C. Schrottmaier, J. B. Kral, T. Weber, and A. Assinger, “Comparison of patient intake of ticagrelor, prasugrel, or clopidogrel on restoring platelet function by donor platelets,” Transfusion, vol. 55, no. 6, pp. 1320–1326, 2015. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Bangalore, Y. Guo, Z. Samadashvili, S. Blecker, J. Xu, and E. L. Hannan, “Everolimus-eluting stents or bypass surgery for multivessel coronary disease,” The New England Journal of Medicine, vol. 372, no. 13, pp. 1213–1222, 2015. View at Publisher · View at Google Scholar · View at Scopus
  16. A. Anisimov, D. Tvorogov, A. Alitalo, V. M. Leppanen, Y. An, and E. C. Han, “Vascular endothelial growth factor-angiopoietin chimera with improved properties for therapeutic angiogenesis,” Circulation, vol. 127, no. 4, pp. 424–434, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. K. Albrecht-Schgoer, W. Schgoer, J. Holfeld, M. Theurl, D. Wiedemann, and C. Steger, “The angiogenic factor secretoneurin induces coronary angiogenesis in a model of myocardial infarction by stimulation of vascular endothelial growth factor signaling in endothelial cells,” Circulation, vol. 126, no. 21, pp. 2491–2501, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. S. Banquet, E. Gomez, L. Nicol et al., “Arteriogenic therapy by intramyocardial sustained delivery of a novel growth factor combination prevents chronic heart failure,” Circulation, vol. 124, no. 9, pp. 1059–1069, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. B. Jiang, J. Chen, L. Xu et al., “Salvianolic acid B functioned as a competitive inhibitor of matrix metalloproteinase-9 and efficiently prevented cardiac remodeling,” BMC Pharmacology, vol. 10, no. 1, p. 10, 2010. View at Publisher · View at Google Scholar · View at Scopus
  20. Y. Joe, M. Zheng, H. J. Kim et al., “Salvianolic acid B exerts vasoprotective effects through the modulation of heme oxygenase-1 and arginase activities,” The Journal of Pharmacology and Experimental Therapeutics, vol. 341, no. 3, pp. 850–858, 2012. View at Publisher · View at Google Scholar · View at Scopus
  21. J. H. Ho and C. Y. Hong, “Salvianolic acids: small compounds with multiple mechanisms for cardiovascular protection,” Journal of Biomedical Science, vol. 18, no. 1, p. 30, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. T. P. Fan, J. C. Yeh, K. W. Leung, P. Y. Yue, and R. N. Wong, “Angiogenesis: from plants to blood vessels,” Trends in Pharmacological Sciences, vol. 27, no. 6, pp. 297–309, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. S. P. Murphy and A. N. Murphy, “Pre-clinical systematic review,” Journal of Neurochemistry, vol. 115, no. 4, p. 805, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. M. R. Macleod, T. O’Collins, D. W. Howells, and G. A. Donnan, “Pooling of animal experimental data reveals influence of study design and publication bias,” Stroke, vol. 35, no. 5, pp. 1203–1208, 2004. View at Publisher · View at Google Scholar · View at Scopus
  25. C. Lin, Z. Liu, Y. Lu et al., “Cardioprotective effect of Salvianolic acid B on acute myocardial infarction by promoting autophagy and neovascularization and inhibiting apoptosis,” The Journal of Pharmacy and Pharmacology, vol. 68, no. 7, pp. 941–952, 2016. View at Publisher · View at Google Scholar · View at Scopus
  26. H. He, M. Shi, X. Yang, X. Zeng, L. Wu, and L. Li, “Comparison of cardioprotective effects using salvianolic acid B and benazepril for the treatment of chronic myocardial infarction in rats,” Naunyn-Schmiedeberg’s Archives of Pharmacology, vol. 378, no. 3, pp. 311–322, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. Y. J. Li, C. L. Duan, and J. X. Liu, “Salvianolic acid A promotes the acceleration of neovascularization in the ischemic rat myocardium and the functions of endothelial progenitor cells,” Journal of Ethnopharmacology, vol. 151, no. 1, pp. 218–227, 2014. View at Publisher · View at Google Scholar · View at Scopus
  28. X.-Z. Yang, Therapeutic Effects and Mechanisms of Danshen on Large Myocardial Infarction in Rats, [M.S. thesis], Zhejiang University, China, 2007.
  29. L.-Y. Fang, “Role of salvianolate in angiogenesis after acute myocardial infarction in rats,” International Journal of Cardiovascular Diseases, vol. 42, no. 4, pp. 256–260, 2015. View at Publisher · View at Google Scholar
  30. Y.-Y. Ma, The Effects of Salidrosid and Salvianolic Acid B on Prnliferation,Migration and Apoptosis of Human Endothelial Progenitor Cells, [Ph.D. thesis], Fudan University, China, 2006.
  31. Y.-J. Li, Explorations on the Material Basis of pro-Angiogenic Actions of Shuangshentongguan and Underlying Mechanisms, [Ph.D. thesis], Academy of Chinese Medical Sciences, China, 2010.
  32. M.-W. Wang, Promotion of Heart Function and Collateral Blood Vessel of Salvianolate on Acute Myocardial Infarction in Swines, Department of Cardiology, the First Affiliated Hospital of NJMi, Nanjing 210029, China, 2008.
  33. N. Liu, L. Yang, B.-y. Mao, G.-c. Xu, and S.-s. Ye, “Salvia extract promotes angiogenesis of myocardium in rats with myocardial infarction,” Chinese Journal of Pathophysiology, vol. 31, no. 8, pp. 1490–1494, 2015. View at Publisher · View at Google Scholar
  34. H.-X. Chen, “Effect of salvianolic acid B on angiogenesis of ischemic myocardium in myocardial ischemia rats,” Chinese Journal of Experimental Traditional Medical Formulae, vol. 18, no. 20, pp. 180–183, 2012. View at Publisher · View at Google Scholar
  35. Y.-C. Fang, Y. C. Fan, G. F. Zhao, and W. Z. Zhang, “Influence of salvianolic acid B on pathomorphology in myocardial infarction tats,” Journal of Tianjin University of Traditional Chinese Medicine, vol. 23, no. 1, pp. 12–14, 2004. View at Publisher · View at Google Scholar
  36. S.-S. Ye, “Effect of salvia extract on the expression levels of VEGF in rats with myocardial infarction,” Lishizhen Medicine and Materia Medica Research, vol. 25, no. 5, pp. 1046–1048, 2014. View at Publisher · View at Google Scholar
  37. X.-L. Pang, “The intervention effect of TCM on acute myocardial infarction in rats,” Tianjin Journal of Traditional Chinese Medicine, vol. 25, no. 4, pp. 325–327, 2008. View at Publisher · View at Google Scholar
  38. H. D. Guo, G. H. Cui, J. X. Tian et al., “Transplantation of salvianolic acid B pretreated mesenchymal stem cells improves cardiac function in rats with myocardial infarction through angiogenesis and paracrine mechanisms,” International Journal of Cardiology, vol. 177, no. 2, pp. 538–542, 2014. View at Publisher · View at Google Scholar · View at Scopus
  39. G. H. Guyatt, A. D. Oxman, V. Montori et al., “GRADE guidelines: 5. Rating the quality of evidence—publication bias,” Journal of Clinical Epidemiology, vol. 64, no. 12, pp. 1277–1282, 2011. View at Publisher · View at Google Scholar · View at Scopus
  40. A. Franco, N. Malhotra, and G. Simonovits, “Social science. Publication bias in the social sciences: unlocking the file drawer,” Science, vol. 345, no. 6203, pp. 1502–1505, 2014. View at Publisher · View at Google Scholar · View at Scopus
  41. S. C. Landis, S. G. Amara, K. Asadullah et al., “A call for transparent reporting to optimize the predictive value of preclinical research,” Nature, vol. 490, no. 7419, pp. 187–191, 2012. View at Publisher · View at Google Scholar · View at Scopus
  42. R. Blankstein, W. Ahmed, F. Bamberg et al., “Comparison of exercise treadmill testing with cardiac computed tomography angiography among patients presenting to the emergency room with chest pain: the Rule Out Myocardial Infarction Using Computer-Assisted Tomography (ROMICAT) study,” Circulation. Cardiovascular Imaging, vol. 5, no. 2, pp. 233–242, 2012. View at Publisher · View at Google Scholar · View at Scopus
  43. G. P. van Hout, S. J. Jansen of Lorkeers, K. E. Wever et al., “Translational failure of anti-inflammatory compounds for myocardial infarction: a meta-analysis of large animal models,” Cardiovascular Research, vol. 109, no. 2, pp. 240–248, 2016. View at Publisher · View at Google Scholar · View at Scopus
  44. J. S. Silvestre, D. M. Smadja, and B. I. Lévy, “Postischemic revascularization: from cellular and molecular mechanisms to clinical applications,” Physiological Reviews, vol. 93, no. 4, pp. 1743–1802, 2013. View at Publisher · View at Google Scholar · View at Scopus
  45. S. B. Freedman and J. M. Isner, “Therapeutic angiogenesis for ischemic cardiovascular disease,” Journal of Molecular and Cellular Cardiology, vol. 33, no. 3, pp. 379–393, 2001. View at Publisher · View at Google Scholar · View at Scopus
  46. N. A. Crossley, E. Sena, J. Goehler et al., “Empirical evidence of bias in the design of experimental stroke studies: a metaepidemiologic approach,” Stroke, vol. 39, no. 3, pp. 929–934, 2008. View at Publisher · View at Google Scholar · View at Scopus